BioNxt Solutions Inc.
BNXT
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -48.45% | 13.77% | -50.93% | 39.00% | 35.56% |
| Total Depreciation and Amortization | -125.15% | -3.55% | 1.20% | -2.91% | -45.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 173.80% | -16.84% | 44.24% | 27.34% | -45.24% |
| Change in Net Operating Assets | -108.56% | -125.17% | 906.22% | -129.18% | -52.35% |
| Cash from Operations | -18.30% | -358.46% | 68.38% | 27.04% | 23.11% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -100.00% | -- | -- |
| Total Debt Issued | 60.66% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -2.10% | -- | -100.00% | 23.05% | -18.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,021.17% | -- | 100.00% | 29.64% | 34.61% |
| Cash from Financing | 43.79% | -- | -100.00% | 25.74% | -15.13% |
| Foreign Exchange rate Adjustments | 200.00% | -71.43% | 250.00% | 100.00% | -94.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 706.45% | 79.74% | -201.45% | 179.57% | -20.24% |